COVID-19 Resource Center

Featured

Editor Insights

Looking at 2023 Key Trends and Insights to Navigate the Future of Value-Based Care

02/13/2024

Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.

Throughout 2023, feature...

02/13/2024

Journal of Clinical Pathways

News

The Ongoing Impact of COVID-19 on Caregivers of Patients With Chronic Lymphocytic Leukemia

03/15/2023

Grace Taylor , MS, MA;

A recent study investigated the impact of COVID-19 on caregivers of patients with CLL during the post-vaccine phase of the pandemic and aimed to identify what resources are needed to better support these caregivers.

A recent study investigated the...

03/15/2023

Journal of Clinical Pathways

Research Reports

Post–COVID-19 Syndrome Clinical Pathway for the US Veterans Health Administration

02/06/2023

Allison M. Gustavson , DPT, PhD;

Johnson Vachachira , NP;

Claudia L. Campos , MD;

Jacob B. Lindheimer , PhD;

Kristina Crothers , MD;

Omar Awan , MD;

Carrie B. May , PsyD;

Cristina Nguyen , BS;

Courtney Sedillo , MSN, FNP-C;

Francis J. Miller Jr., MD;

Lindheimer et al summarize the stepwise diagnostic approach for patients presenting with PCS dyspnea and/or cough in primary care and highlight teleconsultation and telerehabilitation as opportunities to reach those in rural areas or with...

Lindheimer et al summarize the...

02/06/2023

Journal of Clinical Pathways

Research Reports

Treatment and Outcomes Among Hospitalized COVID-19 Patients With Immune-mediated Inflammatory Diseases: An Electronic Health Record Database Cohort Study

08/20/2021

Christopher D. Pericone , PhD;

Kimberly Woodruff , PharmD, PhD;

Emily S. Brouwer , MPH, PharmD, PhD;

Alex Z. Fu , PhD;

Qian Cai , MSPH, MS;

Alex Z Fu, PhD, and colleagues explore treatment journeys and outcomes for hospitalized COVID-19 patients with rheumatoid arthritis, psoriatic arthritis, psoriasis, Crohn's disease, or ulcerative colitis.

Alex Z Fu, PhD, and colleagues...

08/20/2021

Journal of Clinical Pathways

Quiz: Are Patients With Cancer and COVID-19 at Higher Risk for Worse Outcomes?

04/13/2021

Journal of Clinical Pathways

Conference Coverage

Digital Care Delivery Models and Staffing Concerns Amidst the COVID-19 Pandemic

03/03/2021

Journal of Clinical Pathways

Cancer Care in 2021 and Beyond: Catalytic Trends, Entrants, and Developments to Optimize Care During and Post Pandemic

02/22/2021

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

Health care has been traditionally immune to disruptive market forces until the COVID-19 global pandemic in 2020. This pandemic also highlighted the challenges and failings of our current health care system, creating...

Health...

02/22/2021

Journal of Clinical Pathways

Positive Disruption in the COVID-19 Era: AMCCBS Virtual

02/22/2021

Association of Community Cancer Centers

The past year challenged cancer care professionals in ways that were seemingly unimaginable. With the spread of SARS-CoV-2 across the United States, cancer programs and practices were forced to dramatically change...

The...

02/22/2021

Journal of Clinical Pathways

We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access

02/22/2021

Marlon Graf , PhD;

T. Joseph Mattingly II, PhD, PharmD, MBA;

Stacey Hickson , PhD;

Jason Shafrin , PhD;

Christoph Glaetzer , Dipl Kfm;

Rifat Tuly , MPH;

Abstract: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a catastrophic burden in both health and economic costs. Despite the December 2020 emergency use authorizations of two COVID-19 vaccines,...

...

02/22/2021

Journal of Clinical Pathways

Quality Outlook

Recognizing and Testing Telehealth Models in Oncology Care First

02/09/2021

David Blaisdell , BA;

Tom Valuck , MD, JD;

Theresa Schmidt , MA, PMP, CSPO;

In this blog, Tom Valuck, MD, JD, and colleagues explore ways for CMS to incorporate telehealth in oncology alternative payment models.

In this blog, Tom Valuck, MD,...

02/09/2021

Journal of Clinical Pathways

News

Patients With Cancer and COVID-19 Infection are at a Higher Risk for Worse Outcomes

01/21/2021

Journal of Clinical Pathways

News

The Ongoing Impact of COVID-19 on Caregivers of Patients With Chronic Lymphocytic Leukemia

03/15/2023

Grace Taylor , MS, MA;

A recent study investigated the...

03/15/2023

Journal of Clinical Pathways

News

Patients With Cancer and COVID-19 Infection are at a Higher Risk for Worse Outcomes

01/21/2021

Journal of Clinical Pathways

News

Use of Real-World EHR to Identify Disparities for COVID-19 in Patients With Cancer

01/05/2021

Journal of Clinical Pathways

News

Impact of COVID-19-Related Social Distancing on Cancer Outcomes

01/05/2021

Journal of Clinical Pathways

News

Consultation Recordings Support Shared Decision Making in Oncology During COVID-19 Pandemic

01/05/2021

Journal of Clinical Pathways

News

Framework to Alleviate the Impact of the COVID-19 Pandemic on Patients With Cancer

01/05/2021

Journal of Clinical Pathways

News

Medicare Telemedicine Reimbursement Before and After COVID-19

12/17/2020

A partnership between government agencies, clinicians, researchers, patient advocacy groups, and private-sector organizations needs to be created to rapidly test, evaluate, deploy, and pay for new telemedicine care models.

A partnership between government...

12/17/2020

Journal of Clinical Pathways

News

Care Disparities Highlighted by COVID-19 Serve as “Wake-Up Call”

12/17/2020

Journal of Clinical Pathways

News

Cancer Screenings, Diagnosis, and Treatments Decreased During COVID-19 Pandemic

11/03/2020

Journal of Clinical Pathways

News

Impact of the COVID-19 Pandemic on Oncology Practice

10/09/2020

Journal of Clinical Pathways

News

Enhancing Survival in Endometrial Cancer: Impact of Immunotherapy and Chemotherapy Combination Therapy

11/13/2024

Hannah Musick ;

Combining immunotherapy with chemotherapy in the treatment of advanced endometrial cancer, particularly in cases of mismatch repair deficiency, has shown promising results in improving progression-free and overall survival outcomes according...

Combining immunotherapy with...

11/13/2024

Journal of Clinical Pathways

News

Under 50% of Oncology Practices Offer Survivorship Clinics

11/12/2024

Jolynn Tumolo ;

Just 41% of oncology practice groups offer a general survivorship clinic for cancer survivors, according to a study published online in JNCI Cancer Spectrum.

Just 41% of oncology practice...

11/12/2024

Journal of Clinical Pathways

News

Experts Reach Consensus on Myelofibrosis Management, Offering New Hope for Patients

11/08/2024

Lisa Kuhns , PhD, MD;

A comprehensive international consensus program has provided vital clinical recommendations to enhance the treatment landscape for myelofibrosis (MF).

A comprehensive international...

11/08/2024

Journal of Clinical Pathways

News

Advancing Personalized Treatment in Endometrial Cancer With the HECTOR Deep Learning Model

11/06/2024

Juliet Gallagher ;

According to a study published in Nature, endometrial cancer (EC) cases are on the rise, and 10% to 20% of patients with EC experience distant recurrence. In this study, in researchers aimed to predict distant recurrence of EC to improve...

According to a study published...

11/06/2024

Journal of Clinical Pathways

News

Influence of Socioeconomic and Demographic Factors on Myelofibrosis Outcomes

10/30/2024

Juliet Gallagher ;

Addressing socioeconomic disparities may improve survival for patients with myelofibrosis, according to a study published in Annals of Hematology.

Addressing socioeconomic...

10/30/2024

Journal of Clinical Pathways

News

Hypertension and Endometrial Cancer Risk: A Systematic Review and Meta-Analysis

10/25/2024

Grace Taylor , MS, MA;

A systematic review and meta-analysis found a significant association between hypertension and an increased risk of endometrial cancer.

A systematic review and...

10/25/2024

Journal of Clinical Pathways

News

Harnessing the Potential of Abemaciclib in Recurrent Endometrial Cancer Treatment

10/25/2024

Abemaciclib, a CDK4/6 inhibitor used in breast cancer treatment, shows promise in targeting novel mechanisms in endometrial cancer for potential therapeutic benefits in cases of recurrence, particularly in estrogen receptor-positive patients.

Abemaciclib, a CDK4/6 inhibitor...

10/25/2024

Journal of Clinical Pathways

News

Pembrolizumab Plus Adjuvant Chemotherapy for Newly Diagnosed High-Risk dMMR Endometrial Cancer

10/21/2024

Grace Taylor , MS, MA;

Pembrolizumab combined with adjuvant carboplatin-paclitaxel significantly improves disease-free survival in patients with high-risk mismatch repair-deficient endometrial cancer, according to a study published in the Journal of Clinical...

Pembrolizumab combined with...

10/21/2024

Journal of Clinical Pathways

News

False Negatives More Prevalent in Endometrial Cancer Screening for Black Women

10/17/2024

Grace Taylor , MS, MA;

A study published in JAMA Oncology found that Black women are more likely to receive false negative results from transvaginal ultrasounds for endometrial cancer compared to White women, highlighting the need for improved diagnostic methods...

A study published in JAMA...

10/17/2024

Journal of Clinical Pathways

News

Efficacy of Momelotinib in Managing Anemia in Myelofibrosis: Results from the SIMPLIFY-2 Trial

10/16/2024

Grace Taylor , MS, MA;

A study published in Advances in Therapy shows that momelotinib significantly improves anemia and related symptoms in patients with myelofibrosis, particularly those previously treated with ruxolitinib.

A study published in Advances in...

10/16/2024

Journal of Clinical Pathways

Videos

Videos

Future Directions in NSCLC Care: Navigating Pathways, Costs, and Cutting-Edge Therapies

11/14/2024

Sawsan Rashdan , MD;

Dr. Sawsan Rashdan, an associate professor at UT Southwestern Medical Center specializing in lung cancer, discusses the transformative impact of targeted therapies and immunotherapies on NSCLC treatment.

Dr. Sawsan Rashdan, an associate...

11/14/2024

Journal of Clinical Pathways

Videos

Evolving Oncology Pathways, CLL Treatment Advances, and the Role of Multidisciplinary Care Teams

11/12/2024

Shaffee Bacchus , PharmD;

Shaffee Bacchus, PharmD, discusses the evolution of oncology pathways, advancements in chronic lymphocytic leukemia (CLL) treatment, and the importance of multidisciplinary care teams in addressing comorbidities and enhancing patient quality...

Shaffee Bacchus, PharmD,...

11/12/2024

Journal of Clinical Pathways

Videos

Assessing Fixed-Duration Obinutuzumab, Ibrutinib, and Venetoclax in CLL: A 7-Year Follow-Up

11/08/2024

;

Kerry Rogers, MD, provides a 7-year update on her study that evaluated the progression-free survival and factors associated with undetectable minimal residual disease status after treatment with a fixed-duration combination of obinutuzumab,...

Kerry Rogers, MD, provides a...

11/08/2024

Journal of Clinical Pathways

Breaking Down Health Care

Navigating Payer Challenges in Cell and Gene Therapy

11/07/2024

Michael Kolodziej , MD;

John Hennessy , MBA;

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...

In this Breaking Down Health...

11/07/2024

Cancer Care Business Exchange

Videos

Navigating Multidisciplinary Care: Insights on Oncology Practice Integration and Pharmaceutical Partnerships

11/04/2024

John Hennessy , MBA;

John Hennessy, Principal at Valuate Health Consultancy, highlights the importance of multidisciplinary collaboration in oncology care to improve patient outcomes.

John Hennessy, Principal at...

11/04/2024

Journal of Clinical Pathways

Videos

Custom Pathways in Oncology: Innovations, Stakeholder Collaboration, and Value-Based Care

11/01/2024

James Hamrick , MD, MPH;

James Hamrick, MD, MPH, Vice President of Clinical Oncology at Flatiron Health, highlights the importance of custom oncology pathways in enabling real-time updates for oncologists, fostering collaborative implementation teams, and supporting...

James Hamrick, MD, MPH, Vice...

11/01/2024

Journal of Clinical Pathways

Federico Cappuzzo, MD, National Cancer Institute Regina Elena

Videos

The Impact of Subcutaneous Formulation of Atezolizumab on Treatment for Patients with Non-Small Cell Lung Cancer

10/17/2024

Federico Cappuzzo, MD, discusses the benefits of the subcutaneous formulation of atezolizumab compared with the intravenous route.

Federico Cappuzzo, MD, discusses...

10/17/2024

Oncology

Videos

Antibody-Drug Conjugates for Endometrial Cancer

10/10/2024

Mariana Gouveia, MD, gives an overview of the use of antibody-drug conjugates for the treatment of patients with endometrial cancer.

Mariana Gouveia, MD, gives an...

10/10/2024

Oncology

Abigail Zamorano, MD, MPHS, UT Health Houston

Videos

Using the PREMM5 Model for Lynch Syndrome Screening in Colorectal or Endometrial Cancer

10/08/2024

Abigail Zamorano, MD, MPHS, shares insights from a pilot study assessing a clinical algorithm, the the PREMM5 model, to evaluate a patient’s risk of carrying a Lynch Syndrome mutation, particularly in low-resource settings.

Abigail Zamorano, MD, MPHS,...

10/08/2024

Oncology

Breaking Down Health Care

Maximizing the Potential of Precision Medicine

10/07/2024

Michael Kolodziej , MD;

John Hennessy , MBA;

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the economic challenges of precision medicine in health care, including the differences between Medicare and commercial health plans and...

In this Breaking Down Health...

10/07/2024

Cancer Care Business Exchange

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways